Abstract
Fibromyalgia syndrome (FMS) is characterized by systemic pain of unknown etiology and is often accompanied by various psychological symptoms. Research on different parameters in fibromyalgia (FM) indicates that multifactors are involved in its pathophysiology; such as genetic factors, substance P, serotonin, hypothalamic pituitary adrenal axis (HPA), muscles metabolic dysfunction, reactive oxygen species (ROS) and reactive nitrogen species (RNS). Oxidative stress has also been implicated in the pathophysiology of FM; therefore, supplementation with antioxidants may be important in modulation of the effects of ROS in patients with FM.
Similar content being viewed by others
References
Goldenberg DL (1997) Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 9:135–143. doi:10.1097/00002281-199703000-00010
Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40:1571–1579. doi:10.1002/art.1780400905
Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363–367. doi:10.1016/0002-9343(92)90265-D
Houdenhove BV, Luyten P (2006) Stress depression and fibromyalgia. Acta Neurol Belg 149–156
Olson J (2004) Mapping genes for fibromyalgia. NIAMS spotlight on research, fibromyalgia: summaries of research. National institute of arthritis and musculoskeletal and skin diseases
Griep EN, Boersma JW, De Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469–474
Crofford LJ, Pillemer SR, Kalogeras KT (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 11:1583–1592. doi:10.1002/art.1780371105
Ross R, Jones K, Eldredge D (2004) Clinical and biochemical features of atypical and melancholic depression subtypes in fibromyalgia patients. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting
Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992) latelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104–109
Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma tryptophan and other amino acids in primary fibromyalgia. A controlled study. J Rheumatol 19:90–94
Larson AA, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87:201–211. doi:10.1016/S0304-3959(00)00284-0
Vaeroy H, Helle R, Forre O (1998) Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia. New features for diagnosis. Pain 32:21–26. doi:10.1016/0304-3959(88)90019-X
Rauch SL, Shin LM, Phelps EA (2006) Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research—past, present, and future. Biol Psychiatry 60:376–382. doi:10.1016/j.biopsych.2006.06.004
Harris RH, Sundgren PC, Pang Y (2007) Variation in glutamate and glutamine levels within the insula are associated with improvements in clinical and experimental pain in fibromyalgia. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting. Boston, Massachusetts
Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F (1997) Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40(3):446–452. doi:10.1002/art.1780400310
Jeschonneck M, Graohmann G, Hein G, Sprott H (2002) Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 39:917–921. doi:10.1093/rheumatology/39.8.917
Lund N, Bengtsson A, Thorborg P (1986) Muscle oxygen tissue pressure in primary fibromyalgia. Scand J Rheumatol 15:165–173. doi:10.3109/03009748609102084
Titova DC, Oeser A, Chung CP, et al (2007) Oxidative stress in fibromyalgia: relationship to symptoms. Program and abstracts of the American college of Rheumatology (ACR) 71st annual meeting
Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51. doi:10.1016/S0165-0327(00)00199-3
Eisinger J, Gandolfo C, Zakarian H, Ayavou T (1997) Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 5:5–15. doi:10.1300/J094v05n04_02
Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25:188–190. doi:10.1007/s00296-003-0427-8
Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yidizhan H (2005) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int
Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M (2008) Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134(3):489–492
Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11:131–135. doi:10.1179/135100006X116628
Cipollone JVF, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, Laurentis SD, Affaitati G, Cesare DD, Giamberardino AD (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335:151–154. doi:10.1016/S0304-3940(02)01058-3
Richard EH, Kahn K (2007) Current advances in understanding the pathophysiology of Fibromyalgia. American college of Rheumatology. 71st annual meeting
Manuel YKB, Moorkens G, Vertommen J, Noé M, Neve J, De Leeuw I (2000) Magnesium status and parameters of the oxidant–antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19:374–382
Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83. doi:10.1007/s00296-003-0335-y
Jackson MJ, O’Farrell S (1993) Free radicals and muscle damage. Br Med Bull 49(3):630–641
Okumus M, Gokoglu F, Kocaoglu S, Ceceli E, Yorgancioglu ZR (2006) Muscle performance in patients with fibromyalgia. Singapore Med J 47:752–756
Buchwald D, Garrity D (1994) Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 26:2049–2053. doi:10.1001/archinte.154.18.2049
Singh A, Naidu PS, Gupta S, Kulkarni SK (2002) Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 5(4):211–220. doi:10.1089/109662002763003366
Zaidi SM, Al-Qirim TM, Banu N (2005) Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver. Drugs R D 6(3):157–165. doi:10.2165/00126839-200506030-00004
Vijayaraghavan R, Suribabu CS, Sekar B, Oommen PK, Kavithalakshmi SN, Madhusudhanan N, Panneerselvam C (2005) Protective role of vitamin E on the oxidative stress in Hansen’s disease (Leprosy) patients. Eur J Clin Nutr 59(10):1121–1128. doi:10.1038/sj.ejcn.1602221
Cao G, Booth SL, Sadowski JA, Prior RL (1998) Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr 68:1081–1087
Merchant RE, Carmack CA, Wise CM (2000) Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14:167–173. doi:10.1002/(SICI)1099-1573(200005)14:3<167:AID-PTR560>3.0.CO;2-R
Deshpande RA, Adhikary P, Tipnis H (1974) Stored grain pest control agent from Nigella sativa and pogostemon heyneanus. Bull Grain Tech 12:232–234
Nair SC, Salomi MJ, Panikkar B, Panikkar KR (1991) Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. Jethenopharm col 31:75–83
Badary OA, Taha RA, Gamel El Din AM, Abdel Wahab MH (2002) The in vitro antioxidant and pro-oxidant action of thymoquinone and tert butylhydroquinone. Egypt J Biochem Mol Biol 20:1–16
Riaz M, Syed M, Chaudhary FM (1996) Chemistry of the medicinal plants of the genus Nigella. Hamdard Med 39:40–45
Hanafy MSM, Hatem ME (1991) Studies on the antimicrobial activity of Nigella sativa seed. J Ethnopharmacol 34:275–278. doi:10.1016/0378-8741(91)90047-H
Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323–328. doi:10.1002/1099-1573(200008)14:5<323:AID-PTR621>3.0.CO;2-Q
Acknowledgments
This study was financially supported by a grant from Higher Education Commission (H. E. C.), Islamabad, Pakistan.
Conflict of interest statement
The authors do not have any financial conflict.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, R., Mughal, M.S., Arshad, N. et al. Pathophysiology and antioxidant status of patients with fibromyalgia. Rheumatol Int 31, 149–152 (2011). https://doi.org/10.1007/s00296-010-1470-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1470-x